FOLDHealthcareMid-Cap

AMICUS THERAPEUTICS, INC. Insider Trading Activity

Every SEC Form 4 insider transaction reported for AMICUS THERAPEUTICS, INC. (FOLD), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are FOLD insiders buying or selling?

AMICUS THERAPEUTICS, INC. insiders reported 26 open-market buys ($16.2M) and 270 sells ($68.2M) across 296 Form 4 filings — a net selling position of $52.0M.

Source: SEC EDGAR Form 4

Key Statistics (as of Mar 5, 2026)

Total Form 4 filings
296
SEC EDGAR
Insider filers
16
Insider buys (26)
$16.2M
Insider sells (270)
$68.2M

Insider sentiment

Net selling

Net insider flow of $52.0M in net selling.

Recent FOLD insider transactions

DateInsiderRoleTypeSharesPriceValue
Mar 5, 2026Bradley L CampbellPresident and CEOSale22.5K$14.35$322.8K
Jan 23, 2026Bradley L CampbellPresident and CEOSale75.0K$14.31$1.1M
Dec 23, 2025David Michael ClarkChief People OfficerSale25.6K$14.17$363.4K
Dec 17, 2025Bradley L CampbellPresident and CEOSale77.9K$10.86$846.0K
Dec 17, 2025David Michael ClarkChief People OfficerSale25.6K$11.00$282.1K
Dec 4, 2025Bradley L CampbellPresident and CEOSale14.6K$10.01$146.0K
Nov 27, 2025Jeff CastelliChief Development OfficerSale76.2K$10.16$773.7K
Nov 27, 2025David Michael ClarkChief People OfficerSale25.6K$10.10$258.9K
Nov 27, 2025Bradley L CampbellPresident and CEOSale14.6K$10.04$146.5K
Nov 27, 2025Ellen RosenbergChief Legal OfficerSale95.6K$10.02$958.5K
Nov 5, 2025David Michael ClarkChief People OfficerSale25.6K$9.51$243.9K
Feb 22, 2025Bradley L CampbellPresident and CEOSale400$10.00$4.0K
Dec 3, 2024Bradley L CampbellPresident and CEOSale7.5K$10.02$75.1K
Nov 7, 2024Bradley L CampbellPresident and CEOSale7.9K$12.50$98.8K
Nov 4, 2024Bradley L CampbellPresident and CEOSale7.5K$11.46$86.0K
Oct 4, 2024Bradley L CampbellPresident and CEOSale7.5K$10.60$79.5K
Sep 5, 2024Bradley L CampbellPresident and CEOSale7.5K$11.71$87.8K
Aug 6, 2024Bradley L CampbellPresident and CEOSale7.5K$10.34$77.5K
Jul 9, 2024Bradley L CampbellPresident and CEOSale6.1K$10.00$61.0K
Jul 3, 2024Bradley L CampbellPresident and CEOSale1.4K$10.00$14.0K
Jun 5, 2024Bradley L CampbellPresident and CEOSale7.5K$10.00$75.0K
May 3, 2024Bradley L CampbellPresident and CEOSale7.5K$10.07$75.5K
Apr 3, 2024Bradley L CampbellPresident and CEOSale7.5K$11.67$87.5K
Mar 15, 2024John F CrowleyExecutive ChairmanSale31.6K$13.65$431.5K
Mar 6, 2024Margaret G McglynnDirectorSale15.0K$13.35$200.2K

Showing the 25 most recent of 296 Form 4 filings for AMICUS THERAPEUTICS, INC..

Most active FOLD insiders

  • John F Crowley103 filings
  • Bradley L Campbell76 filings
  • Burke W Whitman19 filings
  • Jay Barth17 filings
  • Daphne Quimi11 filings

Ask anything about FOLD insider activity

Use Trabud's AI agent to query AMICUS THERAPEUTICS, INC.'s Form 4 history in plain English — "Show me FOLD CEO purchases this year" or compare it against any other ticker.

Open the AI agent

FOLD insider trading FAQ

Are AMICUS THERAPEUTICS, INC. insiders buying or selling?

Across 296 SEC Form 4 filings, AMICUS THERAPEUTICS, INC. (FOLD) insiders reported 26 open-market purchases totaling $16.2M and 270 sales totaling $68.2M. That is a net selling position of $52.0M.

How many insiders trade FOLD stock?

16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for AMICUS THERAPEUTICS, INC.. The most recent filing was accepted on Mar 5, 2026.

Where does Trabud get FOLD insider trading data?

All FOLD insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content